Search results
Results from the WOW.Com Content Network
Benign prostatic hyperplasia ( BPH ), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [ 1] Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. [ 1] Complications can include urinary tract infections, bladder stones, and ...
Some common drugs for prostate health are associated with a lower risk of dementia with Lewy bodies. Image credit: tdub303/Getty Images. This article originally appeared on Medical News Today
Urology. [ edit on Wikidata] A prostatic stent is a stent used to keep open the male urethra and allow the passing of urine in cases of prostatic obstruction and lower urinary tract symptoms (LUTS). Prostatic obstruction [ 1] is a common condition with a variety of causes. Benign prostatic hyperplasia (BPH) is the most common cause, [ 2] but ...
Dutasteride is used for treating BPH, colloquially known as an "enlarged prostate". [ 8 ] [ 13 ] It is approved by the Food and Drug Administration (FDA) in the U.S. for this indication. [ 14 ] A 2010 Cochrane review found a 25–26% reduction in the risk of developing prostate cancer with 5α-reductase inhibitor chemoprevention .
For premium support please call: 800-290-4726 more ways to reach us
Large studies of patients have also failed to show any correlation between lower urinary tract symptoms and a specific diagnosis. [10] Also, recently a report of lower urinary tract symptoms even with malignant features in the prostate failed to be associated with prostate cancer after further laboratory investigation of the biopsy. [9]
H&E stain. Transurethral resection of the prostate (commonly known as a TURP, plural TURPs, and rarely as a transurethral prostatic resection, TUPR) is a urological operation. It is used to treat benign prostatic hyperplasia (BPH). As the name indicates, it is performed by visualising the prostate through the urethra and removing tissue by ...
Prostatic artery embolization (PAE, or prostate artery embolisation) is a non-surgical technique for treatment of benign prostatic hypertrophy (BPH). [1]The procedure involves blocking the blood flow of small branches of the prostatic arteries using microparticles injected via a small catheter, [2] to decrease the size of the prostate gland to reduce lower urinary tract symptoms.